CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,410 enrolled
Drug / intervention
Intervention focused on identified organ dysfunction(s)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04980274
NCT04980274N/ACompleted

Impact of Admission SOFA Score and 48-hour Delta SOFA on Clinical Outcomes in Critically Ill Patients

Hospital Sao Domingos·observational·Posted Jul 28, 2021·Updated Jul 28, 2021

In Brief

An observational study evaluating Intervention focused on identified organ dysfunction(s) for Critically Ill Patients. Completed, enrolled 1,410 participants across 1 site.

Detailed Summary

Organ dysfunctions are associated with high morbidity and mortality. The SOFA (Sequential Organ Failure Assessment) score developed by Vincent et al. sequentially assesses the presence and severity of dysfunctions in six organ systems: respiratory, cardiovascular, coagulation, hepatic, neurological and renal. Although the SOFA score was created to quantify organ dysfunctions, the obvious relationship between organ dysfunctions and mortality has been widely documented. Dynamic measurements of the SOFA score assess response to treatment and can be used to search for perpetuating sources of severity and reassess the treatment plan. The primary objective of this study will be to assess the impact of an admission SOFA score equal to or greater than 2 and subsequent interventions on outcomes related to the 48-hour delta SOFA on ICU and hospital mortality, length of stay in the ICU, duration of mechanical ventilation, time of vasoactive drug use. Patients will be divided into three groups: those who did not trigger the SOFA trigger on admission to the ICU (Group 1), those who triggered the SOFA trigger and improved on the third day (Group 2) and, finally, those who triggered the SOFA trigger and worsened on the third day (Group 3).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesBrazil
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJul 28, 2021
Enrollment StartJan 1, 2020
Primary CompletionDec 31, 2020
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 4.9 years ago

Interventions

Intervention focused on identified organ dysfunction(s)other

Intervention focused on identified organ dysfunction(s)